Suppr超能文献

脑钠肽在原发性肺动脉高压中的临床意义

Clinical significance of brain natriuretic peptide in primary pulmonary hypertension.

作者信息

Leuchte Hanno H, Holzapfel Michael, Baumgartner Rainer A, Ding Isabelle, Neurohr Claus, Vogeser Michael, Kolbe Tilman, Schwaiblmair Martin, Behr Jürgen

机构信息

Division of Pulmonary Diseases, Department of Internal Medicine I, Ludwig Maximilains University, Klinikum Grosshadern, Munich, Germany.

出版信息

J Am Coll Cardiol. 2004 Mar 3;43(5):764-70. doi: 10.1016/j.jacc.2003.09.051.

Abstract

OBJECTIVES

The aim of this study was to investigate the potential role of brain natriuretic peptide (BNP) levels in the assessment of functional status and right heart performance in primary pulmonary hypertension (PPH).

BACKGROUND

Primary pulmonary hypertension is a progressive disease leading to right heart failure and death. Right heart catheterization and maximal or submaximal exercise tests are employed to assess the course of the disease and the effect of therapeutic interventions. Additional noninvasive and reproducible parameters would be helpful to assess the status of patients with PPH. The natriuretic peptide system is up-regulated in PPH patients. Brain natriuretic peptide (BNP) is produced from the cardiac ventricles and elevated in PPH. The aim of our study was to evaluate the clinical significance of BNP in PPH patients.

METHODS

Correlation analysis was performed for plasma BNP levels of 28 PPH patients and World Health Organization (WHO) functional class (WHO-class), distance walked in 6 min, peak oxygen uptake (peak Vo(2)), and oxygen pulse during spiroergometry and various hemodynamic parameters, including pulmonary vascular resistance (PVR), pulmonary artery pressure (PAP), right atrial pressure (RAP), and cardiac index.

RESULTS

The BNP levels were inversely correlated with the 6-min walk (r = -0.70; p < 0.001) and peak Vo(2) (r = -0.61; p < 0.01), and positive correlation was observed with WHO-class (r = 0.79; p < 0.001). Moreover, BNP levels were also correlated to PVR (r = 0.61; p < 0.01), PAP (r = 0.48; p < 0.05), and RAP (r = 0.78; p < 0.01), and were inversely related to cardiac index (r = -0.48; p < 0.05).

CONCLUSIONS

Our data suggest that plasma BNP levels are closely related to the functional impairment of PPH patients and parallel the extent of pulmonary hemodynamic changes and right heart failure. Serial measurements of plasma BNP concentrations may help improve the management of PPH patients.

摘要

目的

本研究旨在探讨脑钠肽(BNP)水平在评估原发性肺动脉高压(PPH)患者功能状态及右心功能方面的潜在作用。

背景

原发性肺动脉高压是一种进行性疾病,可导致右心衰竭和死亡。右心导管检查以及最大或次最大运动试验用于评估疾病进程及治疗干预效果。额外的非侵入性且可重复的参数将有助于评估PPH患者的病情。利钠肽系统在PPH患者中上调。脑钠肽(BNP)由心室产生,在PPH患者中升高。我们研究的目的是评估BNP在PPH患者中的临床意义。

方法

对28例PPH患者的血浆BNP水平与世界卫生组织(WHO)功能分级(WHO分级)、6分钟步行距离、峰值摄氧量(峰值Vo₂)、运动心肺功能测试期间的氧脉搏以及各种血流动力学参数(包括肺血管阻力(PVR)、肺动脉压(PAP)、右心房压(RAP)和心脏指数)进行相关性分析。

结果

BNP水平与6分钟步行距离呈负相关(r = -0.70;p < 0.001)以及与峰值Vo₂呈负相关(r = -0.61;p < 0.01),与WHO分级呈正相关(r = 0.79;p < 0.001)。此外,BNP水平还与PVR(r = 0.61;p < 日01)、PAP(r = 0.48;p < 0.05)和RAP(r = 0.78;p < 0.01)相关,与心脏指数呈负相关(r = -0.48;p < 0.05)。

结论

我们的数据表明,血浆BNP水平与PPH患者的功能损害密切相关,与肺血流动力学变化程度及右心衰竭情况平行。连续测量血浆BNP浓度可能有助于改善PPH患者的管理。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验